Goldman Sachs and Silvergate Capital sink following Q4 earnings reports Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Activision Blizzard (ATVI) up 36% after Microsoft (MSFT) announced plans to acquire the video game maker for $95.00 per share, in an all-cash transaction valued at $68.7B, inclusive of Activision Blizzard's net cash
- Houghton Mifflin (HMHC) up 8% after Bloomberg reported the company is considering a potential sale
- GlaxoSmithKline (GSK) up 2% after Unilever confirmed its interest in GSK Consumer Healthcare and said that it has approached GSK and Pfizer (PFE) about a potential acquisition of the business
UP AFTER EARNINGS -
DOWN AFTER EARNINGS -
- Silvergate Capital (SI) down 10%
- Goldman Sachs (GS) down 4%
- Signature Bank (SBNY) down 1%
LOWER -
- Unilever (UL) down 9% in New York trading after its GBP 50B bid for the consumer health unit of GSK
- Microsoft (MSFT) down 1% after agreeing to acquire Activision Blizzard in an all-cash transaction valued at $68.7B, inclusive of Activision Blizzard's net cash
- Molecular Parrtners (MOLN) and Novartis (NVS) down 14% and 1%, respectively, after entering into a license agreement under which Novartis will in-license global rights to ensovibep from Molecular Partners
Symbols:
HMHC GSK SBNY FBK GS - $380.90 /
-10.04 (-2.57%)
SI - $138.06 /
+1.655 (+1.21%)
UL MOLN - $31.61 /
+3.515 (+12.51%)
NVS ATVI MSFT PFE Keywords: Fly Intel, Wall Street, Top Stories, Stocks